Screener
BioMarin Pharmaceuticals BMRN Invested capital
Discontinued — last reported Q2 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from BioMarin Pharmaceuticals’s reported figures.
The source filing: BioMarin Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:14 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001048477-26-000016
FAQ
- What is BioMarin Pharmaceuticals's invested capital?
- BioMarin Pharmaceuticals (BMRN) reported invested capital of $9.63B in Q2 2026.
- How has BioMarin Pharmaceuticals's invested capital changed year-over-year?
- BioMarin Pharmaceuticals's invested capital increased by 78.0% year-over-year, from $5.41B to $9.63B.
- What is the long-term trend for BioMarin Pharmaceuticals's invested capital?
- Over 5 years (2020 to 2025), BioMarin Pharmaceuticals's invested capital has grown at a 9.1% compound annual growth rate (CAGR), from $3.51B to $5.42B.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about BioMarin Pharmaceuticals's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude